{"id":"W4380084899","doi":"10.1002/hon.3164_420","title":"Final safety and efficacy results of copanlisib monotherapy in patients with relapsed or refractory iNHL: 6‐year follow‐up of CHRONOS‐1","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Gilead Sciences; Eisai; Sanofi; Servier; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Adverse effect; Rituximab; Follicular lymphoma; Clinical endpoint; Phases of clinical research; Lymphoma; Refractory (planetary science); Gastroenterology; Surgery; Oncology; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002117789,0.0003894182,0.001022488,0.0004001861,0.0004291933,0.0008646963,0.0003128493,0.0004588567,0.002062952],"category_scores_gemma":[0.001452383,0.0001536091,0.001148587,0.0003561864,0.0002345953,0.00057768,0.0003143981,0.001407202,0.0006050934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009235136,"about_ca_system_score_gemma":0.0005672267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006474822,"about_ca_topic_score_gemma":0.0009634537,"domain_scores_codex":[0.9995011,0.0001110471,0.00005422554,0.00009719013,0.0001322004,0.000104199],"domain_scores_gemma":[0.9986727,0.0002156629,0.000428307,0.0001314624,0.0002494165,0.000302416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2064912,0.007309732,0.426499,0.001063516,0.003102035,0.001522986,0.0005923958,0.004601666,0.0478742,0.0003165705,0.01490223,0.2857245],"study_design_scores_gemma":[0.0154038,0.1432352,0.8001631,0.000157481,0.002763987,0.002045717,0.0001426954,0.002402673,0.01478029,0.0003034513,0.01849951,0.0001020447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865562,0.003757268,0.0005916178,0.0002340142,0.00004500383,0.0004064876,0.003475283,0.00007890543,0.004855165],"genre_scores_gemma":[0.9883093,0.0006178691,0.0004542599,0.0004352992,0.00005919556,0.0002983331,0.00829264,0.00001619472,0.001517017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002117789,"threshold_uncertainty_score":0.01120001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03957222822548243,"score_gpt":0.3165948374563731,"score_spread":0.2770226092308906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}